For the year ending 2025-12-31, DFPH made $502,729K in revenue. -$60,606K in net income. Net profit margin of -12.06%.
| Income Statement | 2025-12-31 | 2024-12-31 | ||
|---|---|---|---|---|
| Total operating revenue | 502,729 | 393,412 | ||
| Direct costs-Health Care Patient Service | 205,502 | - | ||
| Direct costs-Health Care Specialty Pharmacy | 220,558 | - | ||
| Direct costs-Clinical Research Trials And Other Revenue | 234 | - | ||
| Selling, general and administrative expense | 105,574 | 107,828 | ||
| Depreciation and amortization | 6,944 | 6,287 | ||
| Direct costs | - | 339,415 | ||
| Total operating expenses | 538,812 | 453,530 | ||
| Loss from operations | -36,083 | -60,118 | ||
| Interest expense, net | 11,276 | 7,496 | ||
| Change in fair value of derivative warrant liabilities | 247 | -619 | ||
| Change in fair value of conversion option derivative liabilities | -12,206 | 2,697 | ||
| Other, net | -925 | -365 | ||
| Total other non-operating expense | -24,654 | -4,545 | ||
| Loss before provision for income taxes | -60,737 | -64,663 | ||
| Income tax benefit | -131 | 0 | ||
| Net loss | -60,606 | -64,663 | ||
| Basic EPS | -0.54 | -0.71 | ||
| Diluted EPS | -0.54 | -0.71 | ||
| Basic Average Shares | 92,389,381 | 75,043,678 | ||
| Diluted Average Shares | 92,389,381 | 75,043,678 | ||
Oncology Institute, Inc. (DFPH)
Oncology Institute, Inc. (DFPH)